Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 25 Carcinoma, Non-Small-Cell Lung 13 Breast Neoplasms 13 Neoplasms 12 Colonic Neoplasms 9 Uterine Cervical Neoplasms 7 Lung Neoplasms 6 Colorectal Neoplasms 6 Urinary Bladder Neoplasms 5 Carcinoma, Renal Cell 5 Uterine Cervical Dysplasia 4 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Myeloid, Acute 4 Esophageal Neoplasms 4 Brain Neoplasms 4 Thrombocythemia, Essential 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Polycythemia Vera 3 Papillomavirus Infections 3 Oropharyngeal Neoplasms 3 Neuroblastoma 3 Mouth Neoplasms 3 Liver Neoplasms 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Glioma 3 Gallbladder Neoplasms 3 Carcinoma, Hepatocellular 3

Interventions

Radiotherapy 4 Surveys and Questionnaires 3 Specimen Handling 2 Iohexol 2 Gemcitabine 2 spartalizumab 1 sodium thiosulfate 1 liposomal doxorubicin 1 X-Rays 1 Watchful Waiting 1 Vorinostat 1 Surgical Procedures, Operative 1 Sunitinib 1 Solutions 1 Saline Solution 1 Re-Irradiation 1 Radiotherapy, Image-Guided 1 Radiosurgery 1 Probiotics 1 Platinum 1 Particle Accelerators 1 Pafolacianine 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Lidocaine 1 Ketamine 1 Injections 1 Immunotherapy, Adoptive 1 Hyperthermic Intraperitoneal Chemotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pelvic Neoplasms × Watchful Waiting × Clear all

NCT04344899 2026-03-11

PORTS

University of Colorado, Denver

Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡